{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:57:27Z","timestamp":1790989047418,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["306698\/2022-6"],"award-info":[{"award-number":["306698\/2022-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State","doi-asserted-by":"publisher","award":["E-26\/201.093\/2022"],"award-info":[{"award-number":["E-26\/201.093\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","award":["23038.009431\/2021-42"],"award-info":[{"award-number":["23038.009431\/2021-42"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbadis.2026.168443","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T21:45:54Z","timestamp":1788126354000},"page":"168443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["EGFR and PGE2 signaling pathways mutually cooperate to promote pro-tumorigenic effects in cervical cancer"],"prefix":"10.1016","volume":"1873","author":[{"given":"Vit\u00f3ria R.","family":"de Azevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella dos S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario J.S.","family":"Farrapo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Martins-Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9ia C.","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson Q.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor H.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168443_bb0010","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jnci\/85.12.958","article-title":"Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia","volume":"85","author":"Schiffman","year":"1993","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"54","key":"10.1016\/j.bbadis.2026.168443_bb0015","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1038\/sj.onc.1204915","article-title":"Mechanisms of cell transformation by papillomavirus E5 proteins","volume":"20","author":"DiMaio","year":"2001","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168443_bb0020","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.tjog.2025.04.006","article-title":"Recent advances in cervical cancer treatment: innovations from early-stage to advanced disease","volume":"64","author":"Lin","year":"2025","journal-title":"Taiwanese Journal of Obstetrics and Gynecology."},{"issue":"18","key":"10.1016\/j.bbadis.2026.168443_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12185992","article-title":"Advances in targeted therapy for the treatment of cervical cancer","volume":"12","author":"Watkins","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189106","article-title":"Emerging biomarkers and molecular targets for precision medicine in cervical cancer","volume":"1879","author":"Garg","year":"2024","journal-title":"Biochimica Et Biophysica Acta (BBA)-Reviews on Cancer."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168443_bb0035","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jacc.2006.07.005","article-title":"Novel\u2014and \u201cneu\u201d\u2014therapeutic possibilities for heart failure","volume":"48","author":"Freedman","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168443_bb0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.bbadis.2026.168443_bb0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm1962","article-title":"EGF\u2013ERBB signalling: towards the systems level","volume":"7","author":"Citri","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2026.168443_bb0050","series-title":"The EGF Receptor Family","first-page":"33","article-title":"Epidermal growth factor receptor: mechanisms of activation and signalling","author":"Jorissen","year":"2003"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168443_bb0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jocn.2006.11.005","article-title":"Targeting malignant glioma survival signalling to improve clinical outcomes","volume":"14","author":"Wong","year":"2007","journal-title":"J. Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168443_bb0060","first-page":"4117","article-title":"Epidermal growth factor receptor expression may correlate with survival through clinical and radiological features of aggressiveness in glioblastoma treated with radiochemotherapy","volume":"35","author":"Tini","year":"2015","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168443_bb0065","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/febs.16240","article-title":"EGFR is a pivotal player of the E2\/ER\u03b2\u2013mediated functional properties, aggressiveness, and stemness in triple-negative breast cancer cells","volume":"289","author":"Kyriakopoulou","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2026.168443_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2147\/OTT.S96309","article-title":"High levels of EGFR expression in tumor stroma are associated with aggressive clinical features in epithelial ovarian cancer","author":"Wang","year":"2016","journal-title":"Onco. Targets. Ther."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168443_bb0075","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ygyno.2007.04.019","article-title":"Is EGFR a moving target during radiotherapy of carcinoma of the uterine cervix?","volume":"106","author":"Cerciello","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168443_bb0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/gyno.2002.6803","article-title":"Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma","volume":"87","author":"Kim","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168443_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158787","article-title":"Prognostic impact of epidermal growth factor receptor overexpression in patients with cervical cancer: a meta-analysis","volume":"11","author":"Tian","year":"2016","journal-title":"PloS One"},{"issue":"7203","key":"10.1016\/j.bbadis.2026.168443_bb0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"9\u201310","key":"10.1016\/j.bbadis.2026.168443_bb0095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cca.2010.12.026","article-title":"Cyclooxygenase-2 in oncogenesis","volume":"412","author":"Rizzo","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168443_bb0100","first-page":"424","article-title":"Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine\/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1","volume":"62","author":"Sales","year":"2002","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168443_bb0105","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-011-1645-z","article-title":"COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma","volume":"18","author":"Akutsu","year":"2011","journal-title":"Ann. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168443_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108860","article-title":"COX2 regulates senescence secretome composition and senescence surveillance through PGE2","volume":"34","author":"Gon\u00e7alves","year":"2021","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168443_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061132","article-title":"Prostaglandin E2-induced COX-2 expressions via EP2 and EP4 signaling pathways in human LoVo colon cancer cells","volume":"18","author":"Hsu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168443_bb0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1471-4159.2002.01145.x","article-title":"Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes","volume":"83","author":"Xu","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2026.168443_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01233","article-title":"The role of eicosanoids in gynecological malignancies","volume":"11","author":"Smith","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.bbadis.2026.168443_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.plefa.2013.04.004","article-title":"The role of prostaglandin E2 in human vascular inflammation","volume":"89","author":"Gomez","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"22","key":"10.1016\/j.bbadis.2026.168443_bb0135","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1111\/bph.13331","article-title":"Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?","volume":"172","author":"O\u2019Callaghan","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168443_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13050942","article-title":"Prostaglandin E2 receptor 4 (EP4) as a therapeutic target to impede breast cancer-associated angiogenesis and lymphangiogenesis","volume":"13","author":"De Paz Linares","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168443_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-012-0342-8","article-title":"Multifaceted roles of PGE2 in inflammation and cancer","volume":"35","author":"Nakanishi","year":"2013","journal-title":"Semin. Immunopathol."},{"issue":"6565","key":"10.1016\/j.bbadis.2026.168443_bb0150","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/379557a0","article-title":"Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors","volume":"379","author":"Daub","year":"1996","journal-title":"Nature"},{"issue":"6764","key":"10.1016\/j.bbadis.2026.168443_bb0155","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/47260","article-title":"EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF","volume":"402","author":"Prenzel","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0160","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3892\/ijo.2013.2234","article-title":"Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression","volume":"44","author":"Zhang","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbadis.2026.168443_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.557280","article-title":"Interplay between EGFR and the platelet-activating factor\/PAF receptor signaling axis mediates aggressive behavior of cervical cancer","volume":"10","author":"Souza","year":"2020","journal-title":"Front. Oncol."},{"issue":"55","key":"10.1016\/j.bbadis.2026.168443_bb0170","article-title":"Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer","volume":"9","author":"de Almeida","year":"2018","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.bbadis.2026.168443_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082374","article-title":"Cooperation between prostaglandin E2 and epidermal growth factor receptor in cancer progression: a dual target for cancer therapy","volume":"15","author":"Finetti","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nm0302-289","article-title":"Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy","volume":"8","author":"Pai","year":"2002","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168443_bb0185","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/me.2004-0022","volume":"18","author":"Sales","year":"2004","journal-title":"Mol. Endocrinol."},{"issue":"19","key":"10.1016\/j.bbadis.2026.168443_bb0190","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.16116","article-title":"PGE2\/EP3\/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells","volume":"8","author":"Bazzani","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168443_bb0195","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1349-7006.2011.01847.x","article-title":"Activation of epidermal growth factor receptor signaling by the prostaglandin E2 receptor EP4 pathway during gastric tumorigenesis","volume":"102","author":"Oshima","year":"2011","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0200","doi-asserted-by":"crossref","first-page":"e2154","DOI":"10.1038\/cddis.2016.61","article-title":"GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4\/EGFR interactive signaling","volume":"7","author":"Parida","year":"2016","journal-title":"Cell Death Dis."},{"issue":"269","key":"10.1016\/j.bbadis.2026.168443_bb0205","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168443_bb0210","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168443_bb0215","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjp.0702518","article-title":"Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs","volume":"126","author":"Giuliano","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2026.168443_bb0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"10.1016\/j.bbadis.2026.168443_bb0225","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.bjc.6605216","article-title":"Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells","volume":"101","author":"Meira","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"9b","key":"10.1016\/j.bbadis.2026.168443_bb0230","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1111\/j.1582-4934.2008.00430.x","article-title":"Cyclooxygenase in normal human tissues\u2013is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?","volume":"13","author":"Zidar","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0235","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1002\/ajh.26076","article-title":"A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis","volume":"96","author":"Palma-Barqueros","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"22","key":"10.1016\/j.bbadis.2026.168443_bb0240","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bbadis.2026.168443_bb0245","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1242\/dmm.030403","article-title":"Mouse models of metastasis: progress and prospects","volume":"10","author":"G\u00f3mez-Cuadrado","year":"2017","journal-title":"Dis. Model. Mech."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168443_bb0250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0167-8140(03)00197-X","article-title":"A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer","volume":"68","author":"Kirwan","year":"2003","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168443_bb0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.flm.2017.06.001","article-title":"Molecular targeted therapy of cancer: the progress and future prospect","volume":"1","author":"Ke","year":"2017","journal-title":"Frontiers in Laboratory Medicine."},{"key":"10.1016\/j.bbadis.2026.168443_bb0265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","article-title":"Molecular targeted therapy: treating cancer with specificity","volume":"834","author":"Lee","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168443_bb0270","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrc1953","article-title":"Integration of EGFR inhibitors with radiochemotherapy","volume":"6","author":"Nyati","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"35","key":"10.1016\/j.bbadis.2026.168443_bb0275","doi-asserted-by":"crossref","first-page":"31182","DOI":"10.1074\/jbc.M506591200","article-title":"Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase","volume":"280","author":"Dittmann","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168443_bb0280","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.7150\/ijbs.72534","article-title":"Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168443_bb0285","first-page":"S43","article-title":"Carcinoma of the cervix uteri","volume":"95","author":"Quinn","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168443_bb0290","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.bbadis.2026.168443_bb0295","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168443_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136893","article-title":"Contributions of the epidermal growth factor receptor to acquisition of platinum resistance in ovarian cancer cells","volume":"10","author":"Granados","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168443_bb0305","article-title":"Elevated COX-2 expression promotes angiogenesis through EGFR\/p38-MAPK\/Sp1-dependent signalling in pancreatic cancer","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168443_bb0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1040-8428(00)00134-7","article-title":"Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy","volume":"38","author":"Yang","year":"2001","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168443_bb0315","first-page":"429","article-title":"Cyclooxygenase-2 is overexpressed in human cervical cancer","volume":"7","author":"Kulkarni","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168443_bb0320","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/1078-0432.CCR-0497-03","article-title":"Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival","volume":"10","author":"Kim","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0325","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/PGP.0b013e318290405a","article-title":"Cox-2, EGFR, and ERBB-2 expression in cervical intraepithelial neoplasia and cervical cancer using an automated imaging system","volume":"33","author":"Fukazawa","year":"2014","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.bbadis.2026.168443_bb0330","doi-asserted-by":"crossref","first-page":"9464","DOI":"10.1038\/s41467-024-53706-3","article-title":"Prostaglandin E2-EP2\/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells","volume":"15","author":"Punyawatthananukool","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0335","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/pharmrev.123.000901","article-title":"Prostaglandin E2 in the tumor microenvironment, a convoluted affair mediated by EP receptors 2 and 4","volume":"76","author":"Santiso","year":"2024","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0340","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/mol.110.069393","article-title":"Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation","volume":"79","author":"Yu","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168443_bb0345","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2012.10.030","article-title":"Celecoxib antagonizes the cytotoxic effect of cisplatin in human gastric cancer cells by decreasing intracellular cisplatin accumulation","volume":"329","author":"Chen","year":"2013","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168443_bb0350","first-page":"298s","article-title":"A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents","volume":"10","author":"Mirzayans","year":"2007","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168443_bb0355","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13014-015-0529-y","article-title":"CFAssay: statistical analysis of the colony formation assay","volume":"10","author":"Braselmann","year":"2015","journal-title":"Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168443_bb0360","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ajpath.2017.10.025","article-title":"The presence of cyclooxygenase 2, tumor-associated macrophages, and collagen alignment as prognostic markers for invasive breast carcinoma patients","volume":"188","author":"Esbona","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"3\u20134","key":"10.1016\/j.bbadis.2026.168443_bb0365","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.molimm.2013.03.019","article-title":"Human follicular dendritic cells promote germinal center B cell survival by providing prostaglandins","volume":"55","author":"Kim","year":"2013","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168443_bb0370","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2011.12.020","article-title":"Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO","volume":"318","author":"Li","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2026.168443_bb0375","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00262-014-1606-z","article-title":"Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis","volume":"63","author":"Hattar","year":"2014","journal-title":"Cancer Immunology Immunotherapy."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168443_bb0380","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/CJI.0b013e3181b91c9c","article-title":"Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2","volume":"33","author":"Mulligan","year":"2010","journal-title":"J. Immunother."},{"issue":"57","key":"10.1016\/j.bbadis.2026.168443_bb0385","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1038\/sj.onc.1205980","article-title":"Cisplatin-induced activation of the EGF receptor","volume":"21","author":"Benhar","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168443_bb0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","article-title":"Preclinical mouse cancer models: a maze of opportunities and challenges","volume":"163","author":"Day","year":"2015","journal-title":"Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926003091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926003091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:24:03Z","timestamp":1790987043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926003091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0925443926003091"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168443","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR and PGE2 signaling pathways mutually cooperate to promote pro-tumorigenic effects in cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168443"}}